Követés
Weijun Wei, Nuclear Medicine Physician, Associate Research Professor
Weijun Wei, Nuclear Medicine Physician, Associate Research Professor
E-mail megerősítve itt: shsmu.edu.cn - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
ImmunoPET: concept, design, and applications
W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo, W Cai
Chemical reviews 120 (8), 3787-3851, 2020
3122020
Magnetic targeting of nanotheranostics enhances cerenkov radiation-induced photodynamic therapy
D Ni, CA Ferreira, TE Barnhart, V Quach, B Yu, D Jiang, W Wei, H Liu, ...
Journal of the American Chemical Society 140 (44), 14971-14979, 2018
1562018
Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors
HJ Song, ZL Qiu, CT Shen, WJ Wei, QY Luo
European Journal of Endocrinology 173 (3), 399-408, 2015
1222015
Noninvasive PET imaging of T cells
W Wei, D Jiang, EB Ehlerding, Q Luo, W Cai
Trends in cancer 4 (5), 359-373, 2018
982018
Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: A meta …
WJ Wei, CT Shen, HJ Song, ZL Qiu, QY Luo
Hellenic journal of nuclear medicine 18 (2), 127-135, 2015
972015
CD146‐targeted multimodal image‐guided photoimmunotherapy of melanoma
W Wei, D Jiang, EB Ehlerding, TE Barnhart, Y Yang, JW Engle, QY Luo, ...
Advanced Science 6 (9), 1801237, 2019
542019
Molecular imaging of β-cells: diabetes and beyond
W Wei, EB Ehlerding, X Lan, Q Luo, W Cai
Advanced Drug Delivery Reviews, 2018
472018
PET imaging of receptor tyrosine kinases in cancer
W Wei, D Ni, EB Ehlerding, QY Luo, W Cai
Molecular cancer therapeutics 17 (8), 1625-1636, 2018
442018
miRNA-106a directly targeting RARB associates with the expression of Na+/I symporter in thyroid cancer by regulating MAPK signaling pathway
CT Shen, ZL Qiu, HJ Song, WJ Wei, QY Luo
Journal of Experimental & Clinical Cancer Research 35, 1-12, 2016
432016
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
WJ Wei, ZK Sun, CT Shen, HJ Song, XY Zhang, ZL Qiu, QY Luo
Theranostics 7 (4), 987-1001, 2017
422017
PET and SPECT imaging of melanoma: the state of the art
W Wei, EB Ehlerding, X Lan, Q Luo, W Cai
European journal of nuclear medicine and molecular imaging 45, 132-150, 2018
382018
ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053
C Wang, Y Chen, YN Hou, Q Liu, D Zhang, H Zhao, Y Zhang, S An, L Li, ...
European Journal of Nuclear Medicine and Molecular Imaging 48, 2749-2760, 2021
372021
Circulating long non-coding RNAs act as biomarkers for predicting 131I uptake and mortality in papillary thyroid cancer patients with lung metastases
ZL Qiu, CT Shen, Z Sun, WJ Wei, XY Zhang, HJ Song, QY Luo
Cellular Physiology and Biochemistry 40 (6), 1377-1390, 2016
372016
MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta‐analysis
WJ Wei, CT Shen, HJ Song, ZL Qiu, QY Luo
Clinical endocrinology 84 (1), 127-133, 2016
372016
A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma
CT Shen, Y Zhang, YM Liu, S Yin, XY Zhang, WJ Wei, ZK Sun, HJ Song, ...
Clinical Endocrinology 87 (6), 844-852, 2017
362017
Circulating tumor cells correlate with clinicopathological features and outcomes in differentiated thyroid cancer
ZL Qiu, WJ Wei, ZK Sun, CT Shen, HJ Song, XY Zhang, GQ Zhang, ...
Cellular Physiology and Biochemistry 48 (2), 718-730, 2018
352018
Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword?
CT Shen, XY Zhang, ZL Qiu, ZK Sun, WJ Wei, HJ Song, QY Luo
Endocrine 58, 176-183, 2017
342017
ImmunoPET imaging of human CD8+ T cells with novel 68Ga-labeled nanobody companion diagnostic agents
H Zhao, C Wang, Y Yang, Y Sun, W Wei, C Wang, L Wan, C Zhu, L Li, ...
Journal of nanobiotechnology 19, 1-11, 2021
332021
Exploiting Nanomaterial‐Mediated Autophagy for Cancer Therapy
W Wei, ZT Rosenkrans, QY Luo, X Lan, W Cai
Small Methods 3 (2), 1800365, 2019
292019
Propranolol sensitizes thyroid cancer cells to cytotoxic effect of vemurafenib
WJ Wei, CT Shen, HJ Song, ZL Qiu, QY Luo
Oncology reports 36 (3), 1576-1584, 2016
292016
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20